购物车
全部删除
您的购物车当前为空
别名 CC-90010
Trotabresib (CC-90010) 是一种具有口服活性的 BET 抑制剂,可用于晚期实体瘤的研究。


为众多的药物研发团队赋能,
让新药发现更简单!
Trotabresib (CC-90010) 是一种具有口服活性的 BET 抑制剂,可用于晚期实体瘤的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 629 | 现货 | |
| 5 mg | ¥ 1,570 | 现货 | |
| 10 mg | ¥ 2,430 | 现货 | |
| 25 mg | ¥ 4,190 | 现货 | |
| 50 mg | ¥ 5,970 | 现货 | |
| 100 mg | ¥ 8,190 | 现货 | |
| 200 mg | ¥ 10,800 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,320 | 现货 |
Trotabresib 相关产品
| 产品描述 | Trotabresib (CC-90010) is an orally active inhibitor of BET and can be used in studies about advanced solid tumors. |
| 别名 | CC-90010 |
| 分子量 | 383.46 |
| 分子式 | C21H21NO4S |
| CAS No. | 1706738-98-8 |
| Smiles | Cn1cc(-c2cc(ccc2OCC2CC2)S(C)(=O)=O)c2ccccc2c1=O |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 45 mg/mL (117.35 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容